These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 24777812)
1. Computational identification of pathogenic associated nsSNPs and its structural impact in UROD gene: a molecular dynamics approach. Doss CG; Magesh R Cell Biochem Biophys; 2014 Nov; 70(2):735-46. PubMed ID: 24777812 [TBL] [Abstract][Full Text] [Related]
2. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach. George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625 [TBL] [Abstract][Full Text] [Related]
3. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT). Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834 [TBL] [Abstract][Full Text] [Related]
4. Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT. Christiansen L; Ged C; Hombrados I; Brons-Poulsen J; Fontanellas A; de Verneuil H; Hørder M; Petersen NE Hum Mutat; 1999; 14(3):222-32. PubMed ID: 10477430 [TBL] [Abstract][Full Text] [Related]
5. Identification of a mutation in the ovine uroporphyrinogen decarboxylase (UROD) gene associated with a type of porphyria. Nezamzadeh R; Seubert A; Pohlenz J; Brenig B Anim Genet; 2005 Aug; 36(4):297-302. PubMed ID: 16026339 [TBL] [Abstract][Full Text] [Related]
6. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach. Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445 [TBL] [Abstract][Full Text] [Related]
7. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex. Doss CG; Nagasundaram N Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641 [TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene. Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: characterization of four novel mutations. Méndez M; Rossetti MV; Gómez-Abecia S; Morán-Jiménez MJ; Parera V; Batlle A; Enríquez de Salamanca R Mol Genet Metab; 2012 Apr; 105(4):629-33. PubMed ID: 22382040 [TBL] [Abstract][Full Text] [Related]
10. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation. Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314 [TBL] [Abstract][Full Text] [Related]
12. Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria. McManus JF; Begley CG; Sassa S; Ratnaike S Blood; 1996 Nov; 88(9):3589-600. PubMed ID: 8896428 [TBL] [Abstract][Full Text] [Related]
13. Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus. Ged C; Ozalla D; Herrero C; Lecha M; Mendez M; de Verneuil H; Mascaro JM Arch Dermatol; 2002 Jul; 138(7):957-60. PubMed ID: 12071824 [TBL] [Abstract][Full Text] [Related]
14. Prediction of functionally significant single nucleotide polymorphisms in PTEN tumor suppressor gene: An in silico approach. Khan I; Ansari IA; Singh P; Dass J FP Biotechnol Appl Biochem; 2017 Sep; 64(5):657-666. PubMed ID: 26800850 [TBL] [Abstract][Full Text] [Related]
15. Prediction and assessment of deleterious and disease causing nonsynonymous single nucleotide polymorphisms (nsSNPs) in human Kamal MM; Teeya ST; Rahman MM; Talukder MEK; Sarmin S; Wani TA; Hasan MM Heliyon; 2024 Jun; 10(12):e32791. PubMed ID: 38994097 [TBL] [Abstract][Full Text] [Related]
16. Prediction of the most deleterious non-synonymous SNPs in the human IL1B gene: evidence from bioinformatics analyses. Abuzaid O; Idris AB; Yılmaz S; Idris EB; Idris LB; Hassan MA BMC Genom Data; 2024 Jun; 25(1):56. PubMed ID: 38858637 [TBL] [Abstract][Full Text] [Related]
17. Impacts of Nonsynonymous Single Nucleotide Polymorphisms of Adiponectin Receptor 1 Gene on Corresponding Protein Stability: A Computational Approach. Saleh MA; Solayman M; Paul S; Saha M; Khalil MI; Gan SH Biomed Res Int; 2016; 2016():9142190. PubMed ID: 27294143 [TBL] [Abstract][Full Text] [Related]
19. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831 [TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations. Christiansen L; Brøns-Poulsen J; Hørder M; Brock A; Petersen NE Scand J Clin Lab Invest; 2005; 65(3):227-35. PubMed ID: 16095052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]